SSR128129E

製品コードS7167 バッチS716701

化学情報

	Synonyms	SSR	Storage (From the date of receipt)	3 years -20°C powder 1 years -80°C in solvent
	化学式	C₁₈H₁₅N₂O₄.Na
	分子量	346.31	CAS No.	848318-25-2
Solubility (25°C)*	体外	DMSO	69 mg/mL (199.24 mM)
		Water	1 mg/mL (2.88 mM)
		Ethanol	Insoluble
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

溶剤液（一定の濃度）を調合する

生物活性

製品説明	SSR128129E is an orally-active and allosteric FGFR1 inhibitor with IC50 of 1.9 μM, while not affecting other related RTKs.
in vitro	SSR128129E exhibits more effective activity in cell assay due to its allosteric mechanism. SSR128129E dose-dependently inhibits FGF2-induced EC proliferation and migration with IC50 of 31 nM and 15.2 nM, respectively. As a multi-FGFR inhibitor, SSR128129E inhibits responses mediated by FGFR1-4 and thus results in the blockage of proliferation and/or migration in various cell lines including mPanc02, HEK-hFGFR2WT, PAE-hFGFR1, hB9-myeloma and HUVEC. ^[1]
in vivo	In Arthritis mice, SSR128129E (30 mg/kg, p.o.) inhibits angiogenesis, inflammation, and bone resorption, and reduces the severity of clinical symptoms. In mice bearing various tumor models, SSR128129E (30 mg/kg, p.o.) inhibits both the growth of primary tumors and metastasis. In addition, SSR128129E inhibits growth of anti-VEGFR2-refractory and -sensitive tumor models, and enhances the antitumor activity of anti-VEGFR2. ^[1] SSR128129E also inhibits arteriosclerosis in a mouse vein graft model and atherosclerosis in apolipoprotein E-deficient mice. ^[2]

プロトコル(参考用のみ)

キナーゼアッセイ	Scintillation Proximity Assay, ¹²⁵I-FGF-2 Binding
キナーゼアッセイ	SPA protein A beads are supplied as a suspension in PBS at 20 mg/mL, then diluted with binding buffer (KCl, 400 mg/L; MgSO₄ 200 mg/L; NaCl 6.4 g/L; NaHCO₃ 3.7 g/L; NaH₂PO₄ 0.141 mg/mL; bis Tris Propane 11.292 g/L; Glucose 4.5 g/L; Gelatin 0.1 %; pH 7.0) at 10 mg/mL. ¹²⁵I-FGF-2 radioligand and FGFR-1IIIcß - Fc Chimera are diluted into binding buffer. Binding was performed on 96-well plates coated with 0.1 % gelatin. Total assay volume is 0.1 mL. Binding of ¹²⁵I-FGF-2 is determined by incubation of SPA beads coated with protein A (0.5 mg/assay) with FGFR-1IIIcß - Fc chimera soluble receptor (5 ng/assay), FGF-2 (20 ng/assay) is used for non-specific binding determinations.
細胞アッセイ	細胞株	Endothelial cells (ECs) and Panc02 tumor cells
	濃度	~100 nM
	反応時間	72 hours
	実験の流れ	Cell proliferation of porcine aortic endothelial (PAE) and tumor cell lines is analyzed on exponentially growing cells that are starved for 16 hours in 0.2 % FBS containing medium and seeded at 4,000 cells/well in 96-well microplates. After exposure to mitogens and/or SSR for 72 hours, cell proliferation is assessed with the use of the CellTiter 96 AQueous One Solution Cell Proliferation Assay according to manufacturer’s instructions. 10 % FBS containing medium is used a positive control.
動物実験	動物モデル	Mouse model of Arthritic and mouse tumor model bearing pancreatic tumor cell line Panc02, murine mammary carcinoma cell line 4T1, murine colon cancer cell line CT26, or human breast MCF7/ADR cell line.
	投薬量	~30 mg/kg
	投与方法	Oral administration

参考

カスタマーフィードバック

: Data from [Data independently produced by , , Exp Mol Med, 2017, 49(9):e374]

: Data from [Data independently produced by , , Oncogenesis, 2017, 6(1):e285]

Selleckの高級品が、幾つかの出版された研究調査結果（以下を含む）で使われた：

FGF-2 promotes angiogenesis through a SRSF1/SRSF3/SRPK1-dependent axis that controls VEGFR1 splicing in endothelial cells [ BMC Biol, 2021, 19(1):173]	PubMed: 34433435
MEKK1 Regulates Chemokine Expression in Mammary Fibroblasts: Implications for the Breast Tumor Microenvironment [ Front Oncol, 2021, 11:609918]	PubMed: 33868996
Extracellular vesicles from human airway basal cells respond to cigarette smoke extract and affect vascular endothelial cells [ Sci Rep, 2021, 11(1):6104]	PubMed: 33731767
Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments. [ Front Oncol, 2020, 10;10:331]	PubMed: 32211337
VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells. [ Int J Oncol, 2018, 52(4):1350-1362]	PubMed: 29532881
API5 induces cisplatin resistance through FGFR signaling in human cancer cells. [Jang HS, et al. Exp Mol Med, 2017, 49(9):e374]	PubMed: 28883546
API5 confers cancer stem cell-like properties through the FGF2-NANOG axis. [Song KH, et al. Oncogenesis, 2017, 6(1):e285]	PubMed: 28092370
Ferulic Acid Exerts Anti-Angiogenic and Anti-Tumor Activity by Targeting Fibroblast Growth Factor Receptor 1-Mediated Angiogenesis. [ Int J Mol Sci, 2015, 16(10):24011-31]	PubMed: 26473837
Integration of signals along orthogonal axes of the vertebrate neural tube controls progenitor competence and increases cell diversity [ PLoS Biol, 2014, 12(7):e1001907]	PubMed: 25026549

長期の保管のために-20°Cの下で製品を保ってください。

人間や獣医の診断であるか治療的な使用のためにでない。

各々の製品のための特定の保管と取扱い情報は、製品データシートの上で示されます。大部分のSelleck製品は、推薦された状況の下で安定です。製品は、推薦された保管温度と異なる温度で、時々出荷されます。長期の保管のために必要とされてそれと異なる温度で、多くの製品は、短期もので安定です。品質を維持するが、夜通しの積荷のために最も経済的な貯蔵状況を用いてあなたの送料を保存する状況の下に、製品が出荷されることを、我々は確実とします。製品の受領と同時に、製品データシートの上で貯蔵推薦に従ってください。